Cuu Long Pharmaceutical JSC (HOSE:DCL)
Vietnam flag Vietnam · Delayed Price · Currency is VND
39,000
+300 (0.78%)
At close: May 22, 2026

HOSE:DCL Income Statement

Millions VND. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,305,6941,321,5891,306,7971,143,9461,015,686703,634
Revenue Growth (YoY)
-4.61%1.13%14.24%12.63%44.35%4.83%
Cost of Revenue
1,142,9481,117,3451,102,093934,032733,585493,482
Gross Profit
162,745204,244204,704209,914282,100210,152
Selling, General & Admin
139,487145,758144,874139,188153,815123,371
Operating Expenses
139,487145,758144,874139,188153,815123,371
Operating Income
23,25958,48559,83070,726128,28586,781
Interest Expense
-52,036-49,129-25,494-30,530-39,627-36,264
Interest & Investment Income
31,45131,82434,27939,66752,71251,929
Currency Exchange Gain (Loss)
-149.78-231.77152.37-2,70577.03-90.68
Other Non Operating Income (Expenses)
-2,093-8,5399.56953.0294.196,058
EBT Excluding Unusual Items
431.0732,41068,77778,111141,542108,412
Gain (Loss) on Sale of Investments
-----1,872
Legal Settlements
2,3022,302----
Pretax Income
2,73334,71168,77778,111141,542110,284
Income Tax Expense
9,47514,62014,63115,97628,62822,528
Earnings From Continuing Operations
-6,74320,09154,14562,134112,91487,756
Minority Interest in Earnings
-578.96-574.7-574.4-416.96-1,273-1,796
Net Income
-7,32219,51653,57161,717111,64185,961
Preferred Dividends & Other Adjustments
--2,0002,0003,0002,000
Net Income to Common
-7,32219,51651,57159,717108,64183,961
Net Income Growth
--63.57%-13.20%-44.72%29.87%29.48%
Shares Outstanding (Basic)
737373737057
Shares Outstanding (Diluted)
737373737057
Shares Change (YoY)
0.02%--4.11%22.02%1.17%
EPS (Basic)
-100.24267.20706.06817.591548.461460.20
EPS (Diluted)
-100.44267.00706.00817.591548.001460.00
EPS Growth
--62.18%-13.65%-47.18%6.03%29.09%
Free Cash Flow
22,384-40,249-103,037-200,343-683,099-123,174
Free Cash Flow Per Share
306.46-551.05-1410.67-2742.89-9736.25-2142.18
Gross Margin
12.46%15.45%15.67%18.35%27.77%29.87%
Operating Margin
1.78%4.42%4.58%6.18%12.63%12.33%
Profit Margin
-0.56%1.48%3.95%5.22%10.70%11.93%
Free Cash Flow Margin
1.71%-3.05%-7.89%-17.51%-67.25%-17.51%
EBITDA
77,987111,49098,088109,004166,420121,054
EBITDA Margin
5.97%8.44%7.51%9.53%16.38%17.20%
D&A For EBITDA
54,72853,00538,25838,27838,13534,273
EBIT
23,25958,48559,83070,726128,28586,781
EBIT Margin
1.78%4.42%4.58%6.18%12.63%12.33%
Effective Tax Rate
346.75%42.12%21.27%20.45%20.23%20.43%
Revenue as Reported
1,305,6941,321,5891,306,797-1,015,686703,634
Source: S&P Global Market Intelligence. Standard template. Financial Sources.